Determination of Warfarin in Human Serum and Serum Ultrafiltrate by Column-switching Liquid Chromatographic System Using a Semi-micro Bore Column.

Y. Kurihara, K. Uesugi, M. Kayano, Yasuo Dohiguchi, Nobuyuki Fukayama
{"title":"Determination of Warfarin in Human Serum and Serum Ultrafiltrate by Column-switching Liquid Chromatographic System Using a Semi-micro Bore Column.","authors":"Y. Kurihara, K. Uesugi, M. Kayano, Yasuo Dohiguchi, Nobuyuki Fukayama","doi":"10.5649/JJPHCS1975.25.169","DOIUrl":null,"url":null,"abstract":"A simple and sensitive reversed-phase high-performance liquid chromatographic method was developed for the analysis of warfarin (WF) in both human serum and serum ultrafiltrate. WF and internal standard (I.S.) were extracted from the serum by simple deproteinization and filtration with a membrane filter. The Column-switching system utilized the short polymer-coated mixed-function (PCMF) phase deproteinization column coupled with a C18 semi-micro analytical column using a mobile phase of acetonitrile, water and NH4H2PO4, followed by a post-column photochemical reaction and fluorimetric detection. The extraction recovery was greater than 80% and the WF and I. S. were separated from the endogenous components in the serum and serumultrafiltrate. The calibration curve was linear from 5 to 1000 ng/mL of serum and 1 to 150 ng/ mL of the serum ultrafiltrate. The limit of quantification was 5 and 1 ng/mL for found to be the serum and serum ultrafiltrate, respectively. The inter and intra-day coefficients of variation for the serum and serum ultrafiltrate ranged less than 10%, respectively. WF was found to be the stable in the serum for a 4-month period during storage at -20°C.","PeriodicalId":14621,"journal":{"name":"Japanese Journal of Hospital Pharmacy","volume":"2 2","pages":"169-175"},"PeriodicalIF":0.0000,"publicationDate":"1999-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Japanese Journal of Hospital Pharmacy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5649/JJPHCS1975.25.169","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 2

Abstract

A simple and sensitive reversed-phase high-performance liquid chromatographic method was developed for the analysis of warfarin (WF) in both human serum and serum ultrafiltrate. WF and internal standard (I.S.) were extracted from the serum by simple deproteinization and filtration with a membrane filter. The Column-switching system utilized the short polymer-coated mixed-function (PCMF) phase deproteinization column coupled with a C18 semi-micro analytical column using a mobile phase of acetonitrile, water and NH4H2PO4, followed by a post-column photochemical reaction and fluorimetric detection. The extraction recovery was greater than 80% and the WF and I. S. were separated from the endogenous components in the serum and serumultrafiltrate. The calibration curve was linear from 5 to 1000 ng/mL of serum and 1 to 150 ng/ mL of the serum ultrafiltrate. The limit of quantification was 5 and 1 ng/mL for found to be the serum and serum ultrafiltrate, respectively. The inter and intra-day coefficients of variation for the serum and serum ultrafiltrate ranged less than 10%, respectively. WF was found to be the stable in the serum for a 4-month period during storage at -20°C.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
半微孔柱开关液相色谱系统测定人血清和血清超滤液中的华法林。
建立了一种简便、灵敏的反相高效液相色谱法分析人血清和血清超滤液中华法林的方法。通过简单的脱蛋白和膜过滤器过滤,从血清中提取WF和内标物。柱切换系统采用短聚合物包被混合功能(PCMF)相脱蛋白柱和C18半微分析柱,流动相为乙腈、水和NH4H2PO4,柱后光化学反应和荧光检测。提取回收率大于80%,从血清和血清超滤液中分离出WF和iss。血清浓度为5 ~ 1000 ng/mL,血清超滤液浓度为1 ~ 150 ng/mL,校准曲线呈线性关系。血清和血清超滤液的定量限分别为5 ng/mL和1 ng/mL。血清和血清超滤液的日内变异系数均小于10%。在-20°C条件下,血清中WF保持稳定4个月。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Assessment and Analysis of the Assessment Criteria for Meta-Analysis Articles:─ Management of Diabetes Pharmacotherapy Based on Meta-Analysis Articles ─ ベネコートBMI-40とBMI-60との苦味マスキング効果の比較 「創薬ボランティアのしおり」,「被験者管理票」の利用と治験コーディネーター業務 Hemodializability of Pimobendan and Its Active Metabolite, UD-CG 212, in Patients with Congestive Heart Failure Undergoing Hemodialysis An Investigation into the Current Management for Patients with Long-Term Withdrawal Periods from Drugs
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1